INTERPATIENT AND INTRAPATIENT VARIABILITY IN VINBLASTINE PHARMACOKINETICS

被引：40

作者：

RATAIN, MJ ^{[1
]}

VOGELZANG, NJ ^{[1
]}

SINKULE, JA ^{[1
]}

机构：

[1] UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,JOINT SECT HEMATOL ONCOL,CHICAGO,IL 60637

来源：

关键词：

D O I：

10.1038/clpt.1987.9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：61 / 67

页数：7

共 17 条

[1] DETERMINANTS OF SERUM ANTIPYRINE HALF-LIVES IN PATIENTS WITH LIVER-DISEASE
BRANCH, RA
HERBERT, CM
READ, AE
[J]. GUT, 1973, 14 (07) : 569 - 573
[2] JACKSON DV, 1984, CANCER CHEMOTH PHARM, V13, P114
[3] JACKSON V, 1981, CANCER TREAT REP, V65, P1043
[4] THE COMPARATIVE CLINICAL-PHARMACOLOGY AND PHARMACOKINETICS OF VINDESINE, VINCRISTINE, AND VINBLASTINE IN HUMAN PATIENTS WITH CANCER
NELSON, RL
[J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (02): : 115 - 127
[5] OHNUMA T, 1985, CANCER RES, V45, P464
[6] POWIS G, 1983, PHARMACOKINETICS ANT, P363
[7] CLINICAL PHARMACOKINETICS OF VINDESINE - REPEATED TREATMENTS BY INTRAVENOUS BOLUS INJECTIONS
RAHMANI, R
MARTIN, M
FAVRE, R
CANO, JP
BARBET, J
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (11): : 1409 - 1417
[8] RAHMANI R, 1985, CANCER TREAT REP, V69, P839
[9] RATAIN MJ, 1986, CANCER RES, V46, P4827
[10] ROOT MA, 1975, FED ANAL CHEM SPECTR, P125